19 May 2026
Pharmaceuticals | Top 5 Selected Papers in 2024–2025 in the “Medicinal Chemistry” Section


1. “A Comprehensive Review on Deep Eutectic Solvents and Its Use to Extract Bioactive Compounds of Pharmaceutical Interest”
by Cátia Ferreira and Mafalda Sarraguça
Pharmaceuticals 2024, 17(1), 124; https://doi.org/10.3390/ph17010124
Available online: https://www.mdpi.com/1424-8247/17/1/124

2. “Discovery of Dual TRPA1 and TRPV1 Antagonists as Novel Therapeutic Agents for Pain”
by Nayeon Do, Dongxu Zuo, Miri Kim, Minseok Kim, Hee-Jin Ha, Peter M. Blumberg, Jihyae Ann, Sun Wook Hwang and Jeewoo Lee
Pharmaceuticals 2024, 17(9), 1209; https://doi.org/10.3390/ph17091209
Available online: https://www.mdpi.com/1424-8247/17/9/1209

3. “Study of the Lipophilicity and ADMET Parameters of New Anticancer Diquinothiazines with Pharmacophore Substituents”
by Daria Klimoszek, Małgorzata Jeleń, Małgorzata Dołowy and Beata Morak-Młodawska
Pharmaceuticals 2024, 17(6), 725; https://doi.org/10.3390/ph17060725
Available online: https://www.mdpi.com/1424-8247/17/6/725

4. “The Potential of Artificial Intelligence in Pharmaceutical Innovation: From Drug Discovery to Clinical Trials”
by Vera Malheiro, Beatriz Santos, Ana Figueiras and Filipa Mascarenhas-Melo
Pharmaceuticals 2025, 18(6), 788; https://doi.org/10.3390/ph18060788
Available online: https://www.mdpi.com/1424-8247/18/6/788

5. “Antidiabetic GLP-1 Receptor Agonists Have Neuroprotective Properties in Experimental Animal Models of Alzheimer’s Disease”
by Melinda Urkon, Elek Ferencz, József Attila Szász, Monica Iudita Maria Szabo, Károly Orbán-Kis, Szabolcs Szatmári and Előd Ernő Nagy
Pharmaceuticals 2025, 18(5), 614; https://doi.org/10.3390/ph18050614
Available online: https://www.mdpi.com/1424-8247/18/5/614

Back to TopTop